[62]
Further, Prothonotary Milczynski rejects
Merck Frosst
as being decided under the
Access to Information
regime. She does this, however, immediately after accepting the evidence of Dr. Liston, who readily admits that his only experience with respect to the confidentiality of documents arises out of the
Access to Information
regime. Novopharm says that if
Merck Frosst
is irrelevant, then so too is the evidence of Dr. Liston.